Literature DB >> 19817507

Medical management of adrenal disease: a narrative review.

K Michalakis1, I Ilias.   

Abstract

Adrenal diseases comprise for a variety of medical endocrine issues, ranging from partial or complete gland insufficiency, to several kinds of adrenal hyperfunction, either of congenital or neoplastic etiology. For hypofunction of the adrenals (partial or complete) the treatment of choice is medical; the mainstay of treatment is hydrocortisone. Patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency are treated with glucocorticoids to control androgen excess. Most benign neoplastic adrenal diseases that cause hyperfunction of the gland are surgically treated, however this may not be always feasible or effective. For Cushing's syndrome ketoconazole controls cortisol's hypersecretion, whereas in case of bilateral idiopathic hyperaldosteronism spironolactone controls hypokalemia and hypertension. For neoplastic adrenomedullary disease surgery is the treatment of choice; medical treatment is used preoperatively (mainly alpha blockers) and in case of disease persistence and /or recurrence (mainly metyrosine). For malignant adrenocortical disease, surgical removal remains the indicated treatment, but if the potential for surgical intervention is limited due to tumor extension, medical treatment can alleviate symptoms of hormone hypersecretion; mitotane in selected patients has good results.

Entities:  

Mesh:

Year:  2009        PMID: 19817507

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  4 in total

Review 1.  Adrenocortical carcinoma: which surgical approach?

Authors:  Bruno Carnaille
Journal:  Langenbecks Arch Surg       Date:  2011-09-27       Impact factor: 3.445

2.  Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylase.

Authors:  Zahida Parveen; Muhammad Sulaman Nawaz; Shazi Shakil; Nigel H Greig; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

Review 3.  Adrenalectomy for Cushing's syndrome: do's and don'ts.

Authors:  D N Paduraru; A Nica; M Carsote; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec

Review 4.  Open versus minimally invasive surgery for suspected adrenocortical carcinoma.

Authors:  Dylan M Buller; Alex M Hennessey; Benjamin T Ristau
Journal:  Transl Androl Urol       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.